Disclosure of Affiliation:
Alain Katic, M.D.
- Grant Support: Abbott Laboratories; Alexza Pharmaceuticals, Inc.; AstraZeneca LP; Bristol-Myers Squibb; Cephalon, Inc; Corcept Therapeutics Incorporated; Cyberonics, Inc.; Dainippon Sumitomo Pharma Co., Ltd.; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Hisamitsu Pharmaceutical Co., Inc. ; Lundbeck; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Organon International Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Sepracor Inc.; Shire Pharmaceuticals Inc.; Takeda Pharmaceutical Company Limited; Wyeth; sanofi-aventis
- Research Support: Abbott Laboratories; Alexza Pharmaceuticals, Inc.; Bristol-Myers Squibb; Cephalon, Inc; Corcept Therapeutics Incorporated; Cyberonics, Inc.; Dainippon Sumitomo Pharma Co., Ltd.; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Hisamitsu Pharmaceutical Co., Inc. ; Lundbeck; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Organon International Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Roche; Sepracor Inc.; Shire Pharmaceuticals Inc.; Somerset Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Targacept, Inc.; Wyeth; sanofi-aventis
- Speakers Bureau: Novartis Pharmaceutical Corporation; Pfizer Inc; Shire Pharmaceuticals Inc.